Nestlé Health Science delivers 6.6% growth, sales surge due to infant formula shortages
date:Jul 29, 2022
ant-based offerings.

The companys infant formula products recorded strong growth following supply shortages in the US market. Nestl was among the companies exporting products to the US under Operation Fly Formula, aiming to boost supplies amid a nationwide shortage with consumers desperate for infant formula.

Sales in Infant Nutrition grew at a double-digit rate, based on strong momentum for human milk oligosaccharides products. Specifically, Latin America, North America and the EU saw market
5/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 15:32